Background {#s1}
==========

Parkinson\'s disease (PD) is the second most common neurodegenerative disorder after Alzheimer\'s disease and is reported to affect up to 1 million Americans over the age 55 and up to 10 million individuals worldwide \[[@R01]\]. In India, with an aging population and increased life expectancy, it is expected that the disease burden due to PD will be enormous, but there is no prospective study to estimate its incidence and mortality. The incidence rates (IRs) in different countries vary from 1.5 to 20 per 100,000 per year \[[@R02]\]. The disease is hallmarked by degeneration of a neurons specifically dopaminergic neurons between the substantianigra (SN) and the striatum. Investigators have reported that a significant number of dopamine producing cells are lost in the substantianigra of PD patients \[[@R03]\]. As these neurons are destroyed, the clinical signs which characterize PD such as the slowed movements, rigidity and tremors start to appear. Another key neuropathological mark of PD is the formation of Lewy bodies, which are cytoplasmic inclusions primarily, composed of the α- synuclein protein. Lewy bodies have been reported in the dopaminergic neurons and other brain regions like the cortex and magnocellular basal forebrain nuclei \[[@R03]\].

Besides the above-mentioned causes, interactions between genetic and environmental factors seem to play a critical role in the development of PD \[[@R04]\]. Several candidate genes and susceptibility loci causing monogenic familial forms of PD have been identified during number of genome wide association studies \[[@R05]\]. PARK16 locus, located on chromosome 1q32, having five candidate genes i.e. NUCKS1, RAB7L1, SLC41A1, SLA45A3 and PM20D1, is significantly associated with PD \[[@R06]\]. NUCKS1 gene encodes a nuclear protein, 27 kD Nuclear casein kinase and cyclin-dependent kinase substrate 1. The conserved regions of NUCKS1 contain several consensus phosphorylation sites for casein kinase II (CK2) and cyclin-dependent kinases (Cdk) and a basic DNA-binding domain. NUCKS1 is similar to the high mobility group (HMG) family, which dominates chromatin remodeling and regulates gene transcription \[[@R07]\]. NUCKS1 plays a significant role in various diseases as susceptibility or potential marker and involve in several regulatory mechanisms \[[@R08]-[@R12]\] Noticeably, NUCKS1 involves in cell growth and proliferation as well as in DNA repair \[[@R13]\]. Using genome wide Association Studies (GWAS) it was found that NUCKS1 is a susceptibility gene for many diseases and a single disease can be associated with multiple SNPs of NUCKS1. However, the same SNP of NUCKS1 for same disease when examined in different races showed that NUCKS1 has diverse expression. Besides, NUCKS1 genotypes exhibit distinct expression for certain diseases. Though exact roles of NUCKS1 in diseases remain unclear, a significant association of expression and transcription levels of NUCKS1 with PD has been observed \[[@R14],[@R15]\]. The rs823093 variant is located in the intron of NUCKS1 gene. The mechanism by which rs823093 variant affects the PD pathogenesis is not yet known. In the present study, using bioinformatics approaches an attempt has been made to examine the functional association of rs823093 polymorphism and PD, with an aim to identify a susceptibility biomarker.

Methodology {#s2}
===========

Regulatory and functional analysis {#s2a}
----------------------------------

Regulatory and functional analysis of rs823093 variant was done using RegulomeDB database and HaploReg v4 tool, respectively. RegulomeDB could annotate genetic variants with known and predicted regulatory DNA elements which included regions of DNAase hypersensitivity, binding sites of transcription factors, promoter regions and binding motifs that play significant role in transcription regulation \[[@R16]\]. These datasets were collected from Gene Expression Omnibus (GEO), the Encyclopedia of DNA Elements (ENCODE) project, and published literature. HaploReg tool was used to annotate the non-coding variants which included information from the 1000 Genomes Project, chromatin state and protein binding annotation from the Roadmap Epigenomics and ENCODE projects, sequence conservation across mammals, the effect of SNPs on regulatory motifs, and expression of genes \[[@R17],[@R18]\].

Functional analysis using Genome Wide Association Study (GWAS) {#s2b}
--------------------------------------------------------------

Functional analysis using Genome wide association study (GWAS) of rs823093 variant was done using PhenoScanner package. This package included publicly available large-scale GWAS data, about 3 billion associations and over 10 million unique single nucleotide polymorphisms (SNPs) and a comprehensive phenotypes data \[[@R19]\]. In the present study, three kinds of functional analyses including the GWAS of diseases, metabolites, and gene expression analysis were performed. The PhenoScanner included 88 GWAS datasets with 76 kinds of diseases or phenotypes to carry out a GWAS analysis \[[@R20]\]. To perform metabolites analysis, PhenoScanner consisted of two metabolomics datasets \[[@R21],[@R22]\]. For gene expression analysis, PhenoScanner included several datasets i.e. Geuvadis, GTEx (version 6), MuTHER, BIOSQTL, BLUEPRINT and Framingham etc.

Validation of NUCKS1 gene expression in Parkinson\'s disease {#s2c}
------------------------------------------------------------

Whole genome expression profiles in Parkinson\'s disease were analyzed to identify the responsible genes associated with Parkinson\'s disease. Here microarray expression data of total 25 samples (including 16 biopsy specimens of Parkinson\'s disease patients, and 9 healthy) from substantia nigra of postmortem human brain of Parkinson\'s disease patients was used \[[@R23]\]. A web tool GEO2R \[[@R24]\] to evaluate whether NUCKS1 gene is significantly deregulated in diseased cases compared with healthy samples at P \< 0.01 significance level was used. Additionally, GeneMANIA tool \[[@R25]\] in Cytoscape4.0 package was used to study the correlation between expressed genes associated with rs823093 variant.

Chart for Methodology: {#s2d}
----------------------

Flowchart of complete methodology is shown in [Figure 1](#F1){ref-type="fig"}.

Results {#s3}
=======

Regulatory and functional analysis of rs823093 variant {#s3a}
------------------------------------------------------

Regulatory analysis of rs823093 variant shows score 6 in RegulomeDB, explaining that variant have binding motif i.e. OTX2 studies using Positional weight matrices (PWM) method. The histone modification study showed that the rs823093 variant is located in enhancer histone marks in blood and strong transcription in various parts of brain, heart, kidney and liver ([Table 1](#T1){ref-type="table"} ). Functional analysis of rs823093 variant using HaploReg tool also shows enhancer histone marks in blood and six altered regulatory motifs i.e. DMBX1, FOXP1, LHX3, GSC, HMBOX1 and OBOX3. First three motifs are involves in brain related proteins.

Association between rs823093 variant and type of disease or phenotype {#s3b}
---------------------------------------------------------------------

GWAS of rs823093 variant identified thirty-eight significant associations at P\<0.01. The variant is also significantly associated with other diseases or phenotypes besides Parkinson\'s disease such as Plateletcrit, Mucinous ovarian cancer, Chronic kidney disease, Particulate matter-associated QT prolongation, Monocyte percentage of white cells, Ulcerative colitis, Late onset Alzheimers disease, Neuroticism, Hip or knee osteoarthritis, Sporadic CreutzfeldtJakob disease and Inflammatory bowel disease etc. (details given in [Table 2](#T2){ref-type="table"}).

Association between rs823093 variant and gene expression {#s3c}
--------------------------------------------------------

The rs823093 variant shows fifty-three significant associations with gene expression at P\<0.01. The analysis predicted significant associations of rs823093 variant with gene expression in multiple human tissues like brain, pancreas, thyroid, cells transformed fibroblasts, colon sigmoid, heart left ventricle, liver, lung, skin, small intestine, stomach, and whole blood, as shown in [Table 3](#T3){ref-type="table"}. These expressed genes include PM20D1, RAB7L1, NUCKS1, SLC41A1, CFHR2, PLIN1, KRBA2, ZNF43, CBX1, PGA4, FGD1, NFASC, SERPINB11, SLC1A7, TMEM54, CCDC28A, SLC45A3 and MFSD4. Significantly, rs823093 variant marks the expression of NUCKS1 gene in blood with P value 5.19e-09, 3.62e-05 and 3.41e-06 and in brain frontal cortex 3.11e-04.

Association between rs823093 variant and metabolites {#s3d}
----------------------------------------------------

Sixteen metabolites showed remarkable associations with rs823093 variant at P\<0.01 such as Glycerol Isobutyrylcarnitine, Pantothenate, Lactate, 4-acetamidobutanoate, LDL, Serotonin (5HT), Gamma-glutamylleucine, Phosphate, Cholesterol, Caprylate, Oleate, Heptanoate, 7-methylguanine, Glucose and Nacetylornithine as listed in [Table 4](#T4){ref-type="table"}.

Validation of NUCKS1 gene expression in Parkinson\'s disease {#s3e}
------------------------------------------------------------

The expression of NUCKS1 gene in Parkinson\'s disease has been evaluated using GEO2R tool. Seven probes i.e. 226880_at, 223661_at, 229353_s\_at, 224582_s\_at, 217802_s\_at, 224581_s\_at and 222424_s\_at were identified in the expression of NUCKS1 gene in gene expression profile of substantianigra of postmortem brain from Parkinson\'s disease patients. Each probe represent different region of NUCKS1 gene and may have same or different transcript. All these probes are found to be deregulated in Parkinson\'s cases compared with healthy individuals. Among these 226880_at is significantly deregulated with P = 2.99e-04 and log2 (fold change) = -0.861([Table 5](#T5){ref-type="table"}). There are 18 different genes, which are regulated by rs823093 as described in [Table 3](#T3){ref-type="table"}. Simultaneously, evaluation of expression of other 17 genes with NUCKS1 revealed that three of them are also have different expression in Parkinson\'s cases i.e. RAB7L1, NFASC and MFSD4 at P\<0.01 and multiple testing correction (MTC) threshold 0.000345 ([Table 5](#T5){ref-type="table"}). Further, network analysis of NUCKS1 gene with other expressed genes regulated by rs823093 variant, revealed that NUCKS1 is co-expressed with ZNF43 and PLIN1genes and ZNF43 shared a protein domain with KRBA2 gene ([Figure 2](#F2){ref-type="fig"}).

Discussion {#s4}
==========

Genome-wide association studies have shown that PARK16 locus has significant association with Parkinson\'s disease \[[@R26],[@R27]\]. NUCKS1 is also reported as one of the important gene at PARK16 locus and has noteworthy association with PD \[[@R16]\]. NUCKS1 encodes a nuclear protein including phosphorylation sites for casein kinase 2 and cyclin-dependent kinases substrate. It is vertebrate specific gene ubiquities in the brain and peripheral tissues \[[@R29]\].The casein kinase 2 has been reported to be involved in altering the dopamine signaling as well as hyper phosphorylation of alpha-synuclein \[[@R30],[@R31]\] and cyclin-dependent kinases, suppress dopamine D1 signaling in the striatum by phosphorylation of postsynaptic protein DARPP-32 \[[@R32]\]. Some previous studies have also reported that cell-cycle protein mediates the degeneration of dopaminergic neurons \[[@R07],[@R33]\]. An earlier study reported that rs823128 variant of NUCKS1 might affect PD risk by altering the transcription factor-binding capability of the genes \[[@R34]\] and also reported as hub gene in a gene network analysis study on Parkinson\'s disease \[[@R35]\].

Hence, NUCKS1 may be crucial for cell cycle progression. Though a definite mechanism of NUCKS1 in PD is not known, it may presumably be involved in the pathogenesis of PD. A complete functional analysis of rs823093 variant of NUCKS1 gene predicated a score of 6, on application of RegulomeDB, using PWM method, suggesting that rs823093 is likely to affect OTX2 motif (chr1: 205689224 - 205689231b) and is associated with histone modification in blood and strong transcription in various parts of brain besides, heart, kidney and liver. Application of HaploReg (version 4.1), also suggested that rs823093 is associated with enhancement of histone modification in blood verifying the findings in HaploReg (version 4.1). PhenoScanner GWAS analysis, showed that rs823093 is not only associated with Parkinson disease, but also is significantly associated with other diseases or phenotypes including Plateletcrit, Mucinous ovarian cancer, Chronic kidney disease, ovarian cancer, Ulcerative colitis, Late onset Alzheimers disease and many other. A study on Alzheimer\'s disease in Han chinese population also suggested that Parkinson\'s disease GWAS-Linked loci i.e. RAB7L1-NUCKS1 is associated with late Alzheimer\'s disease \[[@R36]\]. The rs823114 variant of NUCKS1 also indicates decreased risk of susceptibility to PD in Han Chinese male and association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson\'s disease \[[@R37],[@R38]\].It is interesting that GA haplotype is reported as risk factor for PD and phenoscanner testify that rs823093 is associated with GA haplotype \[39\].

PhenoScanner gene expression analysis showed that rs823093 is significantly associated with expression of multiple genes in multiple human tissues together with NUCKS1. Also rs823093 was identified to be expressively associated with other 16 metabolites including Serotonin (5HT) using PhenoScanner metabolites option.

Interestingly serotogenic dysfunction has a direct relevance to Parkinson\'s disease non-motor symptoms, like depression, fatigue, weight changes, and visual hallucinations \[40\]. Substatianigra of postmortem human brain exhibited different expression of NUCKS1 gene in PD patients as compared with healthy samples (PD = 16; Healthy = 09), likewise the gene expression graph ([Figure 3](#F3){ref-type="fig"}) for 226880_at probe depicts that NUCKS1 is down regulated in PD patients. Additionally, NUCKS1 is co-expressed with ZNF43 and PLIN1 genes where ZNF43 share a protein domain with KRBA2, in network analysis. Therefore it is presume that these three genes may also works as susceptible gene for PD pathogenesis but more study has to be needed.

Conclusion {#s5}
==========

NUCKS1 is reported as one of the significant gene at PARK16 locus and has remarkable connotation with PD but its mechanism is not yet known. In current study a comprehensive functional analysis of rs823093 variant of NUCKS1 gene has been done using gene expression, disease association, network and metabolite analysis. The findings of stated analysis verified the possible association of NUCKS1 gene with PD, which may serve as susceptibility marker for PD.
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###### Histone modification analysis

  Location                    Chromatin State        Tissue
  --------------------------- ---------------------- ------------------------------
  chr1:205689200..205690000   Genic enhancers        Blood
  chr1:205684600..205691400   Strong transcription   Fetal Brain Female
  chr1:205685400..205690800   Strong transcription   Fetal Brain Male
  chr1:205686600..205690200   Strong transcription   Brain Inferior Temporal Lobe
  chr1:205688000..205690600   Strong transcription   Brain Substantia Nigra
  chr1:205689000..205692200   Strong transcription   Brain Hippocampus Middle
  chr1:205682800..205711200   Strong transcription   Fetal Thymus
  chr1:205683400..205693800   Strong transcription   Fetal Adrenal Gland
  chr1:205684600..205693000   Strong transcription   Fetal Kidney
  chr1:205688000..205690000   Strong transcription   Fetal Heart
  chr1:205688000..205690200   Strong transcription   Right Ventricle
  chr1:205688000..205690400   Strong transcription   Sigmoid Colon
  chr1:205688400..205693200   Strong transcription   Liver
  chr1:205680400..205694200   Quiescent/Low          Right Atrium

###### Association between rs823093 and type of disease or phenotype

  Disease or phenotype                                      PMID       P-value    No. of samples
  --------------------------------------------------------- ---------- ---------- ----------------
  Prostate specific antigen levels                          25434496   5.00E-13   NA
  Parkinson\'s disease                                      22438815   1.38E-11   4258
  Parkinson\'s disease                                      19915576   4.88E-09   3509
  Parkinson\'s disease                                      19915575   7.29E-08   5691
  Parkinson\'s disease                                      21248740   7.29E-08   2796
  Parkinson\'s disease                                      25064009   2.22E-06   108990
  Plateletcrit                                              27863252   2.58E-04   173480
  Parkinson\'s disease                                      21738487   1.90E-04   33050
  HbA1c                                                     28898252   1.19E-03   123665
  Body mass index                                           28892062   9.80E-04   173430
  Body mass index in males greater than 50 years of age     26426971   1.70E-03   92442
  Body mass index females                                   28892062   3.95E-04   82438
  Mucinous ovarian cancer                                   28346442   2.60E-03   42090
  Chronic kidney disease                                    26831199   3.30E-03   117165
  Childhood BMI                                             26604143   3.55E-03   35669
  Chronic kidney disease                                    20383146   3.90E-03   62237
  Insulin sensitivity index adjusted for BMI interaction    27416945   4.10E-03   16753
  Particulate matter-associated QT prolongation             28749367   4.56E-03   22158
  Urea                                                      28887542   4.66E-03   9961
  ovarian cancer                                            28346442   5.05E-03   42895
  Monocyte percentage of white cells                        27863252   5.24E-03   173480
  Ulcerative colitis                                        26192919   5.30E-03   27432
  Body mass index adjusted for physical activity in males   28448500   5.85E-03   84503
  Testosterone                                              28887542   6.06E-03   4387
  Body mass index                                           25673413   6.22E-03   339224
  Late onset Alzheimer's disease                            21390209   6.36E-03   3595
  Neuroticism                                               27089181   6.44E-03   170911
  Hip or knee osteoarthritis                                22763110   6.74E-03   18419
  Waist circumference in female smokers                     28443625   7.42E-03   20595
  Body mass index in physically inactive individuals        28448500   8.00E-03   42066
  Diabetic nephropathy                                      16775037   8.01E-03   1795
  Body mass index adjusted for smoking in males             28443625   8.38E-03   102746
  Body mass index in physically inactive individuals        28448500   9.08E-03   46393
  Sporadic Creutzfeldt Jakob disease                        22210626   9.23E-03   7872
  Inflammatory bowel disease                                26192919   9.42E-03   34652
  Granulocyte percentage of myeloid white cells             27863252   9.58E-03   173480
  Body mass index in male non-smokers                       28443625   9.88E-03   78101
  Albumin                                                   28887542   9.93E-03   9961

###### Association between rs823093 and gene expression

  Gene        Tissue                                 No. of sample   Beta      SE        P-value    PMID       Source
  ----------- -------------------------------------- --------------- --------- --------- ---------- ---------- ------------
  PM20D1      Adipose subcutaneous                   385             0.4991    0.1489    9.02E-04   25954001   GTEx
  PM20D1      Testis                                 225             0.6166    0.1796    7.36E-04   25954001   GTEx
  PM20D1      Whole blood                            2116            NA        NA        1.22E-30   27918533   BIOSQTL
  RAB7L1      Adipose subcutaneous                   385             -0.3531   0.09168   1.42E-04   25954001   GTEx
  RAB7L1      Artery tibial                          388             -0.362    0.08334   1.89E-05   25954001   GTEx
  RAB7L1      Brain anterior cingulate cortex BA24   109             -0.6235   0.1707    4.42E-04   25954001   GTEx
  RAB7L1      Brain cortex                           136             -0.4474   0.1162    1.96E-04   25954001   GTEx
  RAB7L1      Breast mammary tissue                  251             -0.3681   0.09399   1.23E-04   25954001   GTEx
  RAB7L1      Esophagus mucosa                       358             -0.2519   0.07573   9.94E-04   25954001   GTEx
  RAB7L1      Esophagus muscularis                   335             -0.3319   0.0768    2.14E-05   25954001   GTEx
  RAB7L1      Heart left ventricle                   272             -0.3227   0.08435   1.70E-04   25954001   GTEx
  RAB7L1      Muscle skeletal                        491             -0.346    0.06334   8.01E-08   25954001   GTEx
  RAB7L1      Skin sun exposed lower leg             414             -0.3987   0.07704   3.86E-07   25954001   GTEx
  RAB7L1      Thyroid                                399             -0.3763   0.07258   3.77E-07   25954001   GTEx
  RAB7L1      Monocytes                              194             -0.9174   0.243     1.60E-04   27863251   BLUEPRINT
  RAB7L1      Neutrophils                            192             -0.8078   0.2442    9.42E-04   27863251   BLUEPRINT
  RAB7L1      Adipose visceral omentum               313             -0.3261   0.07763   3.65E-05   25954001   GTEx
  RAB7L1      Artery aorta                           267             -0.4965   0.1201    5.11E-05   25954001   GTEx
  RAB7L1      Brain hippocampus                      111             -0.9282   0.1895    4.29E-06   25954001   GTEx
  RAB7L1      Colon sigmoid                          203             -0.4021   0.1047    1.75E-04   25954001   GTEx
  RAB7L1      Esophagus gastroesopha-geal junction   213             -0.3007   0.07885   1.89E-04   25954001   GTEx
  RAB7L1      Heart atrial appendage                 264             -0.3142   0.0907    6.44E-04   25954001   GTEx
  RAB7L1      Nerve tibial                           361             -0.2752   0.07424   2.50E-04   25954001   GTEx
  RAB7L1      Pancreas                               220             -0.4918   0.1111    1.63E-05   25954001   GTEx
  RAB7L1      Brain hypothalamus                     108             -0.9381   0.2511    3.35E-04   25954001   GTEx
  RAB7L1      Stomach                                237             -0.4187   0.1214    6.84E-04   25954001   GTEx
  RAB7L1      Whole blood                            2116            NA        NA        1.35E-21   27918533   BIOSQTL
  RAB7L1      Lung                                   383             -0.3165   0.08726   3.35E-04   25954001   GTEx
  NUCKS1      Brain frontal cortex BA9               118             -0.5593   0.1495    3.11E-04   25954001   GTEx
  NUCKS1      Prostate                               132             0.4927    0.1391    4.28E-04   25954001   GTEx
  NUCKS1      Whole blood                            2116            NA        NA        5.19E-09   27918533   BIOSQTL
  NUCKS1      Peripheral blood                       5311            NA        NA        3.41E-06   24013639   Westra-H
  NUCKS1      Lung                                   278             0.2174    0.06255   6.05E-04   25954001   GTEx
  NUCKS1      Whole blood                            369             0.1994    0.04756   3.62E-05   25954001   GTEx
  SLC41A1     Thyroid                                278             -0.3251   0.09241   5.21E-04   25954001   GTEx
  SLC41A1     Thyroid                                399             -0.2909   0.06974   3.88E-05   25954001   GTEx
  SLC41A1     Lymphoblasto-id cell lines             462             NA        NA        3.53E-08   24037378   Geuvadis
  SLC41A1     Brain anterior cingulate cortex BA24   109             -0.467    0.1296    5.21E-04   25954001   GTEx
  CFHR2       Peripheral blood monocytes             1490            NA        NA        4.47E-06   20502693   Zeller
  PLIN1       Whole blood                            5257            -0.0209   0.00473   1.12E-05   28122634   Framingham
  KRBA2       Whole blood                            5257            NA        NA        2.69E-05   28122634   Framingham
  ZNF43       Whole blood                            5257            0.0435    0.01073   5.13E-05   28122634   Framingham
  CBX1        Whole blood                            5257            0.0352    0.00876   5.95E-05   28122634   Framingham
  PGA4        Whole blood                            5257            -0.042    0.01047   6.12E-05   28122634   Framingham
  FGD1        Whole blood                            5257            0.013     0.00326   6.81E-05   28122634   Framingham
  NFASC       Prostate                               87              0.7023    0.1901    4.49E-04   25954001   GTEx
  NFASC       Pituitary                              87              -0.5927   0.1395    6.98E-05   25954001   GTEx
  SERPINB11   Whole blood                            5257            -0.0322   0.00813   7.55E-05   28122634   Framingham
  SLC1A7      Whole blood                            5257            -0.0192   0.00485   7.56E-05   28122634   Framingham
  TMEM54      Whole blood                            5257            -0.0253   0.00644   8.55E-05   28122634   Framingham
  CCDC28A     Whole blood                            5257            0.0227    0.00583   9.89E-05   28122634   Framingham
  SLC45A3     Adipose subcutaneous                   385             0.2693    0.07622   4.72E-04   25954001   GTEx
  MFSD4       Cells transformed fibroblasts          272             0.585     0.1505    7.32E-04   25954001   GTEx

###### Association between rs823093 and metabolites

  Metabolite              No. of sample   Beta      SE        P-value    PMID
  ----------------------- --------------- --------- --------- ---------- ----------
  Glycerol                1735            NA        NA        1.60E-04   21886157
  Isobutyrylcarnitine     1725            NA        NA        3.10E-04   21886157
  Pantothenate            911             NA        NA        3.20E-04   21886157
  Lactate                 24871           0.06257   0.02158   4.65E-03   27005778
  4-acetamidobutanoate    6523            0.016     0.0057    4.92E-03   24816252
  LDL                     19273           0.05838   0.02064   4.99E-03   27005778
  Serotonin (5HT)         5791            0.0281    0.0106    5.04E-03   24816252
  Gamma-glutamylleucine   7354            0.0139    0.005     5.04E-03   24816252
  Phosphate               7341            -0.0113   0.0042    7.04E-03   24816252
  Cholesterol             7365            -0.0127   0.0048    7.41E-03   24816252
  Caprylate               7355            -0.0154   0.0058    7.43E-03   24816252
  Oleate                  7323            -0.0178   0.0067    7.58E-03   24816252
  Heptanoate              7353            -0.0295   0.0112    8.19E-03   24816252
  7-methylguanine         5804            0.0349    0.0133    8.45E-03   24816252
  Glucose                 7325            -0.0099   0.0038    9.16E-03   24816252
  N-acetylornithine       7146            0.0326    0.0126    9.49E-03   24816252

###### Expression analysis of genes including NUCKS1, regulated by rs823093 variant in Parkinson\'s disease dataset

  Probe ID       Gene        t-statistics   Fold change (log2)   P-value
  -------------- ----------- -------------- -------------------- ----------
  239929_at      PM20D1      1.08838876     0.37                 2.87E-01
  218700_s\_at   RAB7L1      2.19856388     0.467                3.72E-02
  218699_at      RAB7L1      2.12573885     0.397                4.34E-02
  243777_at      RAB7L1      -1.36547912    -0.572               1.84E-01
  226880_at      NUCKS1      -4.18256211    -0.861               2.99E-04
  223661_at      NUCKS1      -2.09624443    -0.654               4.61E-02
  224582_s\_at   NUCKS1      -1.72103478    -0.316               9.74E-02
  224581_s\_at   NUCKS1      -1.2063773     -0.178               2.39E-01
  217802_s\_at   NUCKS1      -1.03533831    -0.183               3.10E-01
  222424_s\_at   NUCKS1      -0.775199      -0.142               4.45E-01
  229353_s\_at   NUCKS1      -0.0254664     -0.567               9.80E-01
  225570_at      SLC41A1     -1.88066702    -0.25                7.15E-02
  206910_x\_at   CFHR2       1.40070154     0.268                1.73E-01
  205913_at      PLIN1       -0.49919732    -0.287               6.22E-01
  1558533_at     KRBA2       0.71072732     0.187                4.84E-01
  206695_x\_at   ZNF43       -1.79511489    -0.289               8.45E-02
  222136_x\_at   ZNF43       -0.67058716    -0.111               5.09E-01
  201518_at      CBX1        0.77565557     0.832                4.45E-01
  213265_at      PGA4        0.22672692     0.965                8.22E-01
  204819_at      FGD1        1.7057522      0.364                1.00E-01
  213438_at      NFASC       -0.97811674    -0.189               3.37E-01
  243645_at      NFASC       -0.87218298    -0.304               3.91E-01
  1552463_at     SERPINB11   0.99260234     0.435                3.30E-01
  210923_at      SLC1A7      -0.72614289    -0.288               4.74E-01
  225536_at      TMEM54      -0.86172346    -0.163               3.97E-01
  209479_at      CCDC28A     -1.74253691    -0.345               9.35E-02
  228696_at      SLC45A3     0.5812718      0.124                5.66E-01
  242372_s\_at   MFSD4       -1.11253201    -0.808               2.76E-01
  238862_at      MFSD4       -0.43285076    -0.188               6.69E-01
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